Your browser doesn't support javascript.
loading
Increased risk of malignancy in patients aged over 50 with idiopathic inflammatory myositis compared to patients with osteoarthritis of the knee.
Kim, Hyoungyoung; Sung, Yoon-Kyoung; Choi, Seongmi; Im, Seul Gi; Jung, Sun-Young; Jang, Eun Jin; Yoo, Dae Hyun; Cho, Soo-Kyung.
Affiliation
  • Kim H; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea.
  • Sung YK; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea.
  • Choi S; Health Insurance Policy Research Institute, National Health Insurance Service, Wonju, Republic of Korea.
  • Im SG; Health Insurance Policy Research Institute, National Health Insurance Service, Wonju, Republic of Korea.
  • Jung SY; Department of Statistics, Kyungpook National University, Daegu, Republic of Korea.
  • Jang EJ; College of Pharmacy, Chung-Ang University, Seoul, Republic of Korea.
  • Yoo DH; Department of Information Statistics, Andong National University, Andong, Republic of Korea.
  • Cho SK; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea.
Mod Rheumatol ; 30(5): 870-877, 2020 Sep.
Article in En | MEDLINE | ID: mdl-31442092
ABSTRACT

Objectives:

To estimate risk of malignancy in patients with idiopathic inflammatory myositis (IIM) compared to patients with knee osteoarthritis (OA).

Methods:

Patients with IIM and knee OA aged over 50, who had no history of malignancy, were identified using Korean National claims database from January 2012 to December 2014. They had been observed until a malignancy was diagnosed or up to the end of the study, December 2015. The incidence rate (IR) of malignancy in IIM patients was calculated and compared with knee OA patients using standardized incidence ratio (SIR).

Results:

A total of 634 polymyositis (PM) and 556 dermatomyositis (DM) patients were included. Overall, 100 solid (IR 270.4/10,000 person-years (PY), 95% confidence interval (CI) 217.4-323.4) and 12 hematologic malignancies (IR 32.4/10,000 PY, 95% CI 14.1-50.8) occurred. Compared with knee OA, risk of overall (SIR 1.5, 95% CI 1.2-1.8), solid (SIR 1.4, 95% CI 1.1-1.6), and hematologic malignancy (SIR 5.7, 95% CI 2.5-9.0) were increased in IIM patients. This was due to increased incidence of malignancy in DM (hematologic malignancy, SIR 8.7, 95% CI 2.7-14.7, solid malignancy, SIR 1.5, 95% CI 1.1-1.9).

Conclusion:

Patients with IIM, especially DM, have an increased risk of malignancy compared to patients with knee OA.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoarthritis, Knee / Myositis / Neoplasms Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Mod Rheumatol Year: 2020 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoarthritis, Knee / Myositis / Neoplasms Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Mod Rheumatol Year: 2020 Type: Article